Venture

Providientia tech lea-sanford

Affiliations

Cornell University

Technologies

Research Tool

Indication

Autoimmune & Inflammation

Basic Research

Cardiovascular Disease

Central Nervous System Disorders

Disease Surveillance

Drug Discovery

Oncology

Personalized Medicine

Regenerative Medicine

We use novel insights from changes in cell membrane properties to optimize early-stage toxicity prediction of drug leads while building toward making the cell membrane a druggable target.

 

Providentia Technologies Team:

Lea Sanford